Independent Advisor Alliance Pfizer Inc Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Pfizer Inc stock. As of the latest transaction made, Independent Advisor Alliance holds 234,455 shares of PFE stock, worth $6.06 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

234,455

Previous 210,683 11.28%

Holding current value

$6.06 Million

Previous $5.89 Million 15.12%

% of portfolio

0.25%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $658,484 - $746,203	23,772 Added 11.28%	234,455 $6.79 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $245,400 - $287,564	9,715 Added 4.83%	210,683 $5.89 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $899,962 - $1.03 Million	34,761 Added 20.91%	200,968 $5.58 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $224,900 - $292,121	-8,607 Reduced 4.92%	166,207 $4.79 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $247,798 - $289,652	-7,722 Reduced 4.23%	174,814 $5.8 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $1.32 Million - $1.52 Million	-36,426 Reduced 16.64%	182,536 $6.7 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $712,762 - $927,911	-18,095 Reduced 7.63%	218,962 $8.93 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $157,898 - $206,119	-3,782 Reduced 1.57%	237,057 $12.2 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $62,095 - $75,802	1,419 Added 0.59%	240,839 $10.5 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $68,119 - $80,768	1,464 Added 0.62%	239,420 $12.6 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $791,703 - $981,020	17,305 Added 7.84%	237,956 $12.3 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $19,296 - $28,603	-467 Reduced 0.21%	220,651 $13 Million
Q3 2021 Nov 01, 2021	BUY	$39.25 - $50.42 $178,116 - $228,805	4,538 Added 2.1%	221,118 $9.51 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $302,110 - $342,240	8,413 Added 4.04%	216,580 $8.48 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $139,753 - $157,614	-4,173 Reduced 1.97%	208,167 $7.54 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $3.09 Million - $3.93 Million	-92,370 Reduced 30.31%	212,340 $7.82 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $6.23 Million - $7.31 Million	196,174 Added 180.75%	304,710 $11.2 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $15,933 - $19,329	-529 Reduced 0.49%	108,536 $3.55 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $331,009 - $472,940	12,246 Added 12.65%	109,065 $3.56 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $110,742 - $125,679	3,364 Added 3.6%	96,819 $3.79 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $215,213 - $279,069	-6,624 Reduced 6.62%	93,455 $3.36 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $516,240 - $579,619	13,960 Added 16.21%	100,079 $4.05 Million
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $334,125 - $367,092	8,910 Added 11.54%	86,119 $3.66 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $512,266 - $584,039	13,316 Added 20.84%	77,209 $3.37 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $464,724 - $563,682	13,482 Added 26.74%	63,893 $2.72 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $92,113 - $98,201	2,793 Added 5.87%	50,411 $1.75 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $84,114 - $97,584	2,636 Added 5.86%	47,618 $1.67 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $98,748 - $104,776	2,969 Added 7.07%	44,982 $1.64 Million
Q3 2017 Nov 15, 2017	SELL	$31.0 - $34.15 $45,911 - $50,576	-1,481 Reduced 3.41%	42,013 $1.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,494	43,494 $1.45 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Pfizer Inc Transaction History